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 Dear Editor,  
I would like to submit to your attention the manuscript entitled “Nanoemulsions as delivery systems 
of hydrophobic silybin from silymarin in foods: effect of oil type on silybin solubility, in vitro 
bioaccessibility and stability  ” (Authors: Sonia Calligaris, Piergiorgio Comuzzo, Francesca Bot, 
Giovanna Lippe, Roberto Zironi, Monica Anese, Maria Cristina Nicoli) for consideration for 
publication on Food Research International. 
The use of the flavolignan silybin from silymarin to treat liver diseases has been well documented. 
Indeed, in recent years attempts have been made to develop pharmaceutical preparations with 
increased silybin bioavailability. At the same time no information is available on ways to improve 
its bioaccessibility in foods. Due to silybin chemical and physical properties, lipid-based delivery 
systems, such as nanoemulsions, could be effectively used to incorporate this nutraceuticals in 
functional foods. The choice of the lipid medium appears particularly critical, since the chemical 
and physical characteristics of the lipid carrier could greatly affect the solubility and the stability of 
the compound to be delivered. 
The aim of this research was to study the potential for nanoemulsion delivery systems to carry 
silybin from silymarin into foods. To this purpose, different carrier oils (sunflower oil, extra virgin 
olive oil and castor oil) were used to prepare silymarin loaded nanoemulsions. The physical and 
chemical stability of nanoemulsions was studied during storage at 20 °C. Also, the effect of oil type 
on the silybin in vitro bioaccessibility was evaluated. 
Results showed that silybin can be successfully incorporated into physically stable nanoemulsions 
prepared with the different oils. The oil type used slightly affected the silybin in vitro 
bioaccessibility. On the contrary, the oil nature influenced the nanoemulsion particle size as well as 
silybin stability during storage: silybin underwent degradation, showing lower stability in extra 
virgin and sunflower oil than in castor oil. Results also showed that silymarin did not affect the 
oxidation kinetics of the carrier oils. 
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Abstract  13 
The purpose of this study was to investigate the potential of nanoemulsion delivery systems 14 
to carry silybin from silymarin. To this purpose, different carrier oils (i.e. sunflower oil, extra 15 
virgin olive oil and castor oil) were used to prepare silymarin loaded nanoemulsions. The 16 
effect of oil type on the silybin solubility and in vitro bioaccessibility was evaluated. 17 
Moreover, the physical and chemical stability of nanoemulsions was studied by measuring 18 
particle size, silybin concentration, oxygen consumption and hydroperoxide formation during 19 
storage at 20 °C.  20 
Results showed that silybin can be successfully incorporated into physically stable 21 
nanoemulsions prepared with the different oils. The oil type used slightly affected the silybin 22 
in vitro bioaccessibility. On the contrary, the oil nature influenced the nanoemulsion particle 23 
size as well as silybin stability during storage: silybin underwent degradation, showing lower 24 
stability in extra virgin and sunflower oil than in castor oil. Results also showed that 25 
silymarin did not affect the oxidation kinetics of the carrier oils. 26 
 27 
Keywords: silybin, silymarin, delivery, nanoemulsion, stability, bioaccessibility 28 
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1. Introduction 30 
Silymarin is a flavolignans extract of Silybum marianum. The flavolignan silybin or silybinin 31 
is the most abundant biologically active compound of silymarin. The use of silymarin to treat 32 
liver diseases, such as cirrhosis, hepatitis, alcoholic liver disease and toxin exposure has been 33 
well documented (Flora, Hahn, Rosen, & Benner, 1998; Fraschini, Demartini, & Esposti, 34 
2002). These biological effects are attributed to the antioxidant, antifibrotic, anti-35 
inflammatory, anti-lipid-peroxidative and anti-carcinogenic activity of silymarin components 36 
(Basaga, Poli, Tekkaya, & Ara, 1997; Luper, 1998; Yang, Liu, & Liu, 2004). 37 
Although results can be hardly summarized, studies on the liver-protective capacity of 38 
silymarin (Loguercio & Festi, 2011) and cell oxidation mechanisms (Dehmlow, Murawski, & 39 
de Groot, 1996; Zielinska-Przyjemska & Wiktorowicz, 2006) evidenced an important 40 
inhibitory effect of silymarin flavonoids on cell enzymes (e.g. lipoxygenase) involved in 41 
inflammatory reactions, whereas reaction with O2-⋅ occurred to a lesser extent (Dehmlow et 42 
al., 1996). Despite this, clinical application and therapeutic efficiency of sylimarin 43 
flavolignans are limited due to their poor bioavailability. As known, molecule physical 44 
properties may greatly affect its bioavailability. At ambient temperature, silybin is in 45 
crystalline state and has low water solubility (Gazak et al., 2004). In recent years, attempts 46 
have been made to develop pharmaceutical preparations with increased silybin bioavailability 47 
(Jia et al., 2010; Li, Yuan, Huang, Zhou, & Liu, 2010; Javed, Kohli, & Ali, 2011; Parveen, 48 
Baboota, Ali, Ahuja, Vasudev, & Ahmad, 2011), while no information is available on ways to 49 
improve its bioaccessibility in foods. According to Rao and McClements (2012), lipid-based 50 
delivery systems for food application, such as microemulsions, nanoemulsions, liposomes, 51 
solid lipid nanoparticles, polymeric nanoparticles, filled hydrogel particles, can be effectively 52 
used to incorporate poorly water-soluble nutraceuticals in functional foods. As known, 53 
nanoemulsions are thermodynamically unstable colloidal systems containing small lipid 54 
droplets dispersed in an aqueous medium (Rao & McClements, 2012). Generally, they show 55 
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good stability to gravitational separation and particle aggregation becoming a good 56 
component to be added to foods that have to be processed and stored under different 57 
conditions. Nanoemulsions have been actually proposed to increase the solubility and stability 58 
of bioactive molecules, such as quercitin (Pool, Mendoza, Xiao, & McClements, 2013), 59 
polymethoxyflavone (Li, Zheng, Xiao, & McClements, 2012) and curcumin (Ahmed, Li, 60 
McClements, & Xiao, 2012), to be incorporated into foods. The choice of the lipid medium 61 
appears particularly critical, since the chemical and physical characteristics of the lipid carrier 62 
greatly affect the solubility of the compound to be delivered. Also, the presence of bioactive 63 
molecule crystals may negatively affect nanoemulsion physical stability, leading to possible 64 
undesired phase separation during food processing and storage, as well as reduction of the 65 
bioavailability of the selected component that may not be adsorbed in this form into the 66 
gastrointestinal tract (Giacomelli et al., 2002; Kawabata, Wada, Nakatani, Yamada, & Onoue, 67 
2011).  68 
The aim of this research was to study the potential for nanoemulsion delivery systems to 69 
carry silymarin, and thus silybin, into foods. To this purpose, different carrier oils (sunflower 70 
oil, extra virgin olive oil and castor oil) were used to prepare silymarin loaded 71 
nanoemulsions. The physical and chemical stability of nanoemulsions was studied during 72 
storage at 20 °C. Also, the effect of oil type on the silybin in vitro bioaccessibility was 73 
evaluated.  74 
 75 
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2. Materials and methods 77 
2.1. Materials 78 
Silymarin extract containing 210 mg/g of silybin, 2,2-diphenyl-1-picrylhydrazyl free radical 79 
(DPPH·), lipase from porcine pancreas, porcine bile extract, di-hydrated calcium chloride, 80 
Tween 80, sodium azide, ethyl acetate, HPLC grade methanol, isooctane, 2-propanol, 1-81 
butanol, ammonium thiocyanate, cumene hydroperoxide, analytical grade hydrochloric acid 82 
and sodium hydroxide were from Sigma Aldrich (St. Luois, MO, USA). Sodium chloride, 83 
barium chloride, ferrous sulphate, monosodium dihydrogen phosphate, disodium hydrogen 84 
phosphate and 85% w/v phosphoric acid were from Carlo Erba Reagents (Milano, Italy). 85 
Analytical standard grade silybin and naringenin-7-O-glucoside were from Extrasynthese 86 
(Genay, France). Sunflower oil, extra virgin olive oil and castor oil were purchased in a local 87 
market. 88 
 89 
2.2. Nanoemulsion preparation  90 
The oil phase was prepared by mixing silymarin powder (2.5 mg/g) and Tween 80 (10 mg/g) 91 
in sunflower oil, extra virgin olive oil or castor oil. The systems were stirred in the dark until 92 
the silymarin was completely dissolved. No recrystallization events were observed before 93 
emulsion preparation. The aqueous phase consisted of deionised water added with 0.1 mg/g of 94 
sodium azide, to avoid microbial spoilage during the storage experiments. The stock 95 
emulsions were prepared by mixing 20% (w/w) oil phase with 80% (w/w) aqueous phase with 96 
a high speed blender for 1 min at 9000 rpm (Polytron, PT 3000, Cinematica, Littau, Swiss). 97 
Aliquots of 250 mL of the stock emulsions were homogenised at 10 L/h flow rate by two 98 
passes at 150 MPa through a two stage high pressure homogeniser provided with cylindrical 99 
tungsten carbide homogenising valves (Panda PLUS 2000, Gea Niro Soavi, Parma, Italy). 100 
Aliquots of 18 mL of the nanoemulsions were inserted into 20 mL colourless glass vials, 101 
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sealed with butyl septa and metallic caps and stored at 20 °C in a thermostatic cell for up to 102 
50 days.   103 
2.3. Analytical determinations  104 
2.3.1. Particle size 105 
The mean diameter of emulsion droplets was measured by using the dynamic light scattering 106 
instrument Particle Sizer NICOMPTM 380 ZLS (PSS NICOMP Particle Sizing System, Santa 107 
Barbara, California, USA). Samples were diluted 1:1000 (v/v) with deionised water prior to 108 
the analysis to avoid multiple scattering effects. The angle of observation was 90°. Solution 109 
refractive index and viscosity were set at 1.333 and 1.0 cP, respectively, corresponding to the 110 
values of pure water at 20 °C. Particle mean diameter corresponding to volume distribution 111 
was calculated by NICOMP Distribution Analysis.   112 
 113 
2.3.2. Silybin solubility  114 
Aliquots of 3 mL of sunflower oil, castor oil, extra virgin olive oil, Tween 80, deionized water 115 
or an oil and Tween 80 mixture (1:1 v/v) were introduced in 5.0 mL capacity vials and excess 116 
amount of silymarin was added (2% w/w). Samples were kept at a constant temperature 117 
(25±1.0 °C) under shaking for 72 h to reach equilibrium (Parveen et al., 2011). The samples 118 
were centrifuged at 13100 g for 10 min (MiniSpin, Eppendorf, Hamburg, Germany) and the 119 
solubilised silybin in the supernatant was then recovered and quantified by HPLC analysis. 120 
 121 
2.3.3. Silybin concentration  122 
Silybin extraction was performed by introducing 1 g supernatant or nanoemulsion into 10 mL 123 
Pyrex tubes, added with 5 mL water:methanol mixture (20:80 v/v), and manually shaken for 2 124 
min. The tubes were then treated for 15 min in an ultrasonic bath (25 °C) and finally 125 
centrifuged at 1000 g for 10 min (Labofuge I, Heraeus Christ GmbH, Osterode am Harz, 126 
Germany). Samples were then stored overnight at -20 °C, to improve the phase separation. 127 
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The upper water-methanol phase was filtered on 0.20 µm pore size nylon membranes (Albet-128 
Hahnemühle, Barcelona, Spain), and analysed for silybin concentration by reverse-phase 129 
HPLC according to the slightly modified method of Kvasnička, Bìba, Ševčìk, Voldřich, and 130 
Kràtkà (2003). Analyses were performed by a LC-2010 AHT liquid chromatographic system 131 
(Shimadzu, Kyoto, Japan) equipped with an integrated UV-visible detector. A 4 µm packed 132 
150 x 4.6 mm C18 column (Synergi Polar, Phenomenex, Torrance, CA), thermostated at 35 133 
°C, was used. The elution was in gradient mode using a mixture of 0.5% (v/v) aqueous 134 
phosphoric acid (solvent A) and methanol (solvent B) as mobile phase at a flow rate of 1 135 
mL/min. Gradient was set as follows: solvent B was held at 36% for the first 5 min, increased 136 
to 45% in 1 min and held at this level for 25 min; then 100% solvent B was reached in 2 min 137 
and held for 5 min, before to be lowered in 2 min to the initial level (36%). The sample 138 
injection volume and the detection wavelength were 10 µL and 288 nm, respectively. 139 
Quantitative analysis was carried out by comparing the silybin peak area with the results of a 140 
calibration line, obtained by injecting silybin standard solutions (in water:methanol, 20:80 141 
v/v). Calibration line was linear (R2 = 0.999) in the 0.5 to 18.0 mg/L concentration interval. 142 
 143 
2.3.4. Chain breaking activity 144 
The chain-breaking activity was measured following the methodology of Brand-Williams, 145 
Cuvelier, and Berset (1995). The bleaching rate of the stable free radical 2,2-diphenyl-1-146 
picrylhydrazyl (DPPH·) was monitored at 515 nm. A volume of 1.85 mL of 6.1x10-5 M 147 
DPPH· methanol solution was used. The reaction was started by the addition of 150 µL of 148 
sample, previously solubilised with methanol. The DPPH· bleaching was followed at 515 nm 149 
(Uvikon 860, Kontron Instruments, Milano, Italy) at 25 °C for at least 10 min. In all cases the 150 
DPPH· bleaching rate was proportional to the sample concentration added to the medium. The 151 
reaction rate of DPPH· bleaching was computed according to the following equation 152 
(Manzocco, Anese, & Nicoli, 1998): 153 
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




  3	  (eq. 1) 154 
where k is the DPPH· bleaching rate, A0 is the initial absorbance value, and A is the 155 
absorbance at increasing time, t. The chain-breaking activity was expressed as the slope (k) 156 
obtained from eq. 1 per milligram of dry matter (A-3/min·gdm), assuming that all of the sample 157 
dry matter possessed antioxidant capacity.  158 
 159 
2.3.5. Oxygen concentration 160 
Oxygen concentration was measured by an OxySense® fluorimeter (OxySense Inc., Dallas, 161 
TX, USA). Aliquots of 18 mL of the nanoemulsions were introduced into 20 mL colourless 162 
glass vials. Preliminarily, an oxygen sensitive sensor (O2xyDot®, OxySense Inc., Dallas, TX, 163 
USA) was pasted on approximately 1 cm from the bottom edge of the internal surface of the 164 
vials, by using an oxygen permeable glue (OxySense Inc.). When the sensor is illuminated by 165 
a pulsed blue light, a red fluorescent light is emitted, that is measured by the fluorimeter. The 166 
decrease of the O2xyDot® fluorescence lifetime, due to dynamic oxygen quenching, is 167 
proportional to the oxygen concentration in the sample. Sample temperature was measured 168 
simultaneously, by a sensor located in the reader pen of the fluorimeter (Li, Ashcraft, 169 
Freeman, Stewart, Jank, & Clark, 2008). Results were expressed as mg/L of oxygen. 170 
 171 
2.3.6. Lipid hydroperoxide concentration  172 
Lipid hydroperoxide concentration was determined following the methods of Shantha and 173 
Decker (1994) and Katsuda, McClements, Migioranza, and Decker (2008). In particular, 3 mL 174 
nanoemulsion were mixed three times with 15 mL isooctane:2-propanol (3:1 v/v) solution and 175 
vortexed for 10 s. After centrifugation for 2 min at 2000 g, the clear upper layer was collected 176 
(0.20 mL) and mixed with 2.8 mL methanol:1-butanol (2:1 v/v) solution, 15 µL of 3.94 mol/L 177 
ammonium thiocyanate solution and 15 µL of 0.0072 mol/L ferrous ion solution (prepared 178 
through the mixture of 0.132 mil/L BaCl2 and 0.144 mol/L FeSO4). After 20 min incubation 179 
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at room temperature, absorbance was measured at 510 nm with a spectrophotometer 180 
(Shimadzu, UV-2501PC, Japan). Hydroperoxide concentration was determined using cumene 181 
hydroperoxide standard curve.  182 
 183 
2.3.7. Silybin in vitro bioaccessibility 184 
In vitro digestion. A dynamic in vitro digestion model was used to study the influence of 185 
emulsion composition on silybin bioaccessibility. The methods of Zangerberg, Mullertz, 186 
Kristensen, and Hovgard (2001a and 2001b) and Mun, Decker, Park, Weiss, and McClements 187 
(2006) were followed with some modifications. 0.75 mL nanoemulsion was mixed with 188 
phosphate buffer (pH 7) and heated at 37 ⁰C for 10 min in a water bath. Then, the pH of the 189 
sample was adjusted to 7.00 with 2 M NaOH and 4 mL bile extract (46.9 g/L in phosphate 190 
buffer at pH 7) and 1 mL calcium chloride (110 g/L in deionized water) were added. The pH 191 
was adjusted to 7.00 if necessary. Finally, 2.5 mL of freshly prepared lipase suspension (24 192 
g/L in phosphate buffer at pH 7) was added to the mixture. The pH of the mixture was 193 
monitored and maintained at 7.00 by adding 0.1 M NaOH. The volume of NaOH added to the 194 
sample was recorded and used to calculate the concentration of free fatty acids (FFA) 195 
generated during lipolysis. The extent of lipolysis was determined as follows: 196 
 197 
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 •100    (eq. 2) 198 
 199 
To calculate the amount of NaOH required for complete lipolysis, it was assumed that 1 200 
molecule of sunflower oil, extra virgin olive oil or castor oil consumed 2 molecule of NaOH 201 
(Yu & Huang, 2012), each oil molecule being hydrolysed by pancreatic lipase into two free 202 
fatty acids and one monoacylglycerol molecule. 203 
In vitro bioaccessibility determination. The in vitro bioaccessibility of silybin was evaluated 204 
after the in vitro digestion was completed. The digest was immediately centrifuged (XL-70 205 
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Ultracentrifuge, Beckman, Palo Alto, CA, USA) at 165000 g at 4 °C for about 70 min. After 206 
centrifugation, the sample was separated into an opaque sediment phase (pellet) and a clear 207 
phase containing the mixed micelles (supernatant). Silybin was extracted from both the digest 208 
and the micelles by liquid-liquid extraction. Briefly, 20 mL digest was introduced in 50 mL 209 
Pyrex tubes and mixed with 200 µL of 218.8 g/L hydrochloric acid and 100 µL of naringenin-210 
7-O-glucoside methanol solution (0.73 g/L). 10 mL ethyl acetate was then added and the 211 
tubes were subjected to manual shaking (5 min) followed by immersion in ultrasonic bath (1 212 
h, 40 °C). The sample was then centrifuged (1000 g, 10 min) and the organic phase separated. 213 
Manual extraction and ultrasound treatment were repeated twice and the ethyl acetate extracts 214 
concentrated to a final volume of approximately 1 mL, in a vacuum centrifuge (Univapo 100 215 
H, UniEquip GmbH, Freital, Dresden, Germany). Silybin quantification in the concentrated 216 
extracts was carried out by HPLC as reported above (Paragraph 2.3.3.). The bioaccessibility 217 
(%) was defined as the percentage ratio between silybin concentration in the mixed micelles 218 
and the silybin concentration in the digest. In addition, to allow a better traceability of the 219 
repartition of the active compound between the pellet and micelles, the pellet was also 220 
analysed for silybin content. To this purpose, the sediment was re-suspended in 5 mL 221 
methanol and 100 µL 218.8 g/L hydrochloric acid. Extraction was performed by manual 222 
shaking (5 min) followed by immersion in ultrasonic bath (40 °C for 1 h). Samples were 223 
finally filtered on 0.20 µm pore size nylon membranes (Albet-Hahnemühle, Barcelona, 224 
Spain), and silybin content was determined by HPLC as reported above (Paragraph 2.3.3.). 225 
Mass balance of silybin in pellet and micelles evidenced the complete recovery of the 226 
bioactive compound.  227 
 228 
2.4. Statistical analysis 229 
The results are averages of at least three measurements taken from different samples and are 230 
reported as means ± SD. Analyses of variance (ANOVA) was performed with significance 231 
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level set at p<0.05 (Statistica for Windows, ver. 5.1, Statsoft Inc. Tulsa, USA, 1997). The 232 
Tukey procedure was used to test for differences between means. 233 
3. Results and discussion 234 
 235 
3.1. Silybin solubility  236 
The solubility of silybin in water, selected oils and Tween 80 is shown in Table 1. In 237 
accordance with the literature, the solubility of silybin in water was negligible (Gazak et al., 238 
2004; Yang et al., 2013). Silybin presented the highest solubility in castor oil followed by 239 
extra virgin olive oil and sunflower oil. As known, among the selected oils, castor oil is the 240 
most polar oil due to its high content of ricinoleic acid. This result is consistent with the data 241 
reported by Yang et al. (2013) and seems to indicate that a certain degree of polarity of the oil 242 
phase might favour silybin solubility. Data on the surfactant Tween 80 support this hypothesis 243 
showing silybin solubility one order of magnitude higher than in the oils. As reported in the 244 
literature, Tween 80 is actually used as surfactant in different nanoemulsions for drug delivery 245 
(Parveen et al., 2011; Yang et al., 2013). Furthermore, silybin solubility was determined in 246 
mixes of sunflower oil, extra virgin olive oil or castor oil, and Tween 80 in 1:1 (v/v) ratio. 247 
Results showed that in all mixtures the silybin solubility had a value comparable to that found 248 
in the Tween 80 alone.  249 
To compare the performances of different nanoemulsions to carrying silybin, before emulsion 250 
preparation 2.50 mg/g silymarin, corresponding to 0.525 mg/g silybin, was added to 251 
sunflower oil, extra virgin olive oil or castor oil containing 10 mg/g Tween 80. At this level, 252 
silybin was completely solubilized in the mixture.  253 
 254 
3.2. Physical properties of silymarin enriched nanoemulsions 255 
Table 2 shows the mean particle diameter of sunflower oil, extra virgin olive oil and castor oil 256 
based nanoemulsions enriched with silymarin. Control samples prepared without silymarin 257 
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showed results not significantly different from the bioactive enriched counterparts (data not 258 
shown). Although the samples had relatively small mean particle diameters, appreciable 259 
differences in the values among the three types of nanoemulsions can be observed, the one 260 
prepared with castor oil showing higher values. As emulsion properties are greatly affected by 261 
the nature of the oil used (McClements, 2005), these results can be attributed to differences in 262 
chemical properties among the oils considered. In particular, the higher particle size of 263 
nanoemulsion with castor oil can be due to higher viscosity and polarity of castor oil in 264 
comparison with extra virgin olive oil and sunflower oil. Neither significant increase in 265 
nanoemulsions particle size nor visible sediments at the bottom of the test vials were found 266 
during storage at 20 °C for up to 50 days. These results suggest that silymarin did not undergo 267 
separation and re-crystallisation phenomena during storage.  268 
 269 
3.3.  Silybin in vitro bioaccessibility of silymarin enriched nanoemulsions  270 
The effect of carrier oil on the silybin in vitro bioaccessibility in nanoemulsions was studied. 271 
As well known, silymarin carrying triacylglycerols have to be decomposed into free fatty 272 
acids and monoglycerides to allow the bioactive molecule to be released and subsequently 273 
incorporated into the mixed micelles, i.e. made of bile salts and lipolytic products, to be 274 
transferred to the epithelium cells (Hofmann & Borgstrom, 1964). To monitor the rate and 275 
extent of lipid digestion, the formation of free fatty acids from the nanoemulsions during 276 
simulated small intestine digestion was measured (Figure 1). The free fatty acids release 277 
steadly increased in the first minutes of the digestion, suggesting that the lipase promptly 278 
attached to the oil droplets surface due to an efficient displacement of the surfactant layer by 279 
the bile salts (Qian, Derek, Xiao, & McClements, 2012). In our experimental conditions, the 280 
free fatty acids release during the in vitro digestion was not affected by the carrier oil type, 281 
which is consistent with previous results (Hur, Joo, Lim, Decker, & McClements, 2011). The 282 
oils used were actually all composed of long chain fatty acids, the chain length being an 283 
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influencing factor of the extent and rate of in vitro lipolysis. Moreover, our results clearly 284 
show that in all cases the free fatty acids release was almost complete (around 80-90% 285 
digestion). The silybin concentration in the mixed micelles (i.e. silybin bioaccessibility) and 286 
precipitated pellets obtained from the digest was then measured (Table 3). Results showed 287 
that the carrier oil only slightly influenced the silybin in vitro bioaccessibility. In fact, 288 
independetly of oil type, silybin concentration in the micelles was approximately 25-30%, 289 
indicating that most of the bioactive compound incorporated into the nanoemulsions was not 290 
available for absorption.  291 
 292 
3.4. Chemical properties of silymarin enriched nanoemulsions 293 
Despite a huge number of papers deal with the mechanisms of silymarin biological activity, to 294 
our knowledge the effect of flavonoids from silymarin on food lipid oxidation has not been 295 
well investigated. Figure 2 shows the changes in oxygen concentration of sunflower oil, extra 296 
virgin olive oil and castor oil containing nanoemulsions enriched with silymarin as a function 297 
of storage time at 20 °C. Nanoemulsions not containing silymarin were used as controls. 298 
Oxygen concentration decreased faster in nanoemulsions containing sunflower oil, followed 299 
by nanoemulsions with extra virgin olive oil and castor oil. Such a reactivity rank is consistent 300 
with the unsaturation degree of the incorporated oils, sunflower oil having a higher value than 301 
extra virgin olive oil, which in turn has a greater number of carbon-carbon double bonds than 302 
castor oil. No significant differences in oxygen concentration were found between 303 
nanoemulsions with and without silymarin. This result suggests that silymarin did not act as 304 
an oxygen scavenger, in agreement with the pionering data reported by Dehmlow et al. 305 
(1996), who found a negligible capacity of silybin to react with O2-⋅ species. Figure 3 shows 306 
the changes in hydroperoxide concentration of nanoemulsion with or without silymarin during 307 
storage. It can be observed that the hydroperoxide concentration changed during storage with 308 
different kinetics depending on the nature of the carrier oil, the sunflower oil and castor oil 309 
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containing emulsions being the most and the least susceptible to oxidation, respectively. 310 
However, also in this case, the evolution of hydroperoxides in the nanoemulsions enriched 311 
with silymarin did not significantly differ from those of the respective nanoemulsions without 312 
the bioactive molecule. These results further indicate that silymarin incorporation into 313 
nanoemulsions did not influence the pathway of the oxidative reactions occuring in oils. 314 
However, they contrast with data on the liver protective effect of silymarin, that is generally 315 
attributed to the antioxidant activity of the bioactive molecule (Shaker, Mahmoud, & Mnaa, 316 
2010). To have insights on the chain breaking activity of silymarin extract used in this study, 317 
the DPPH· assay was performed. Only a weak ability of silymarin to scavenge the DPPH· 318 
radical was measured (i.e. 0.14 ± 0.06 A-3/min·gdm). Such a value was much lower than the 319 
chain breaking activity of α-tocopherol and Trolox, that were 0.94±0.24 and 8.47±0.45 A-320 
3/min·gdm, respectively. These results are in agreement with the data of the literature (Gazak et 321 
al., 2004; Henning et al., 2014). In particular, Henning et al. (2014) reported that the Silybum 322 
marianum extracts had antioxidant properties lower than other dietary supplements, such as 323 
pomegranate, resveratol and green tea. It is noteworthy that other authors found that silymarin 324 
had high in vitro radical scavenging activity (Koksal, Gulcin, Beyza, Sarikaya, & Bursal, 325 
2009). 326 
Despite the results described above, silybin concentration in nanoemulsions greatly decreased 327 
during storage (Figure 4). Such a decrease was greater in sunflower oil based nanoemulsions 328 
followed by extra virgin olive oil and castor oil containing samples. In particular, at 50 days 329 
storage, silybin losses were 60% and 55% in nanoemulsions containing sunflower oil and 330 
extra virgin olive oil, respectively, whereas 25% reduction of silybin content was found in the 331 
nanoemulsion with castor oil. These discrepancies in silybin degradation kinetics might be 332 
brought back to differences in the bioactive reactivity in the media considered. It can be 333 
inferred that in sunflower oil and extra virgin olive oil containing nanoemulsions, silybin 334 
could be preferably located at the interface, near the emulsifier layer, where a higher polarity 335 
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would favour its degradation. On the contrary, when castor oil was used as a carrier, silybin 336 
would be preferably located inside the oil droplets, being thus less prone to degradation. 337 
Possible silybin degradation by reactive species generated from oil oxidative reactions may 338 
not be ruled out. Gazak et al. (2004) actually described a number of oxidized derivatives of 339 
silybin. These compounds were obtained under strong oxidative conditions (e.g., H2O2 in 340 
NaHCO3, iodine in glacial acetic acid, high temperature). In our experimental conditions, the 341 
greater the oil susceptibility to oxidation, and thus the formation of oxidation products, the 342 
greater the silybin degradation. It is a matter of fact that due to the scarcity of information 343 
available in the literature, further experiments are needed to understand the fate of silybin in 344 
food related environments.  345 
 346 
Conclusions  347 
The present study is a first attempt to develop delivery systems for incorporating silymarin 348 
into functional foods. Results showed that silymarin can be successfully incorporated into 349 
physically stable nanoemulsions prepared with different carrier oils. The oil type used slightly 350 
affected the in vitro bioaccessibility of the main bioactive compound of silymarin, i.e. silybin. 351 
Although silymarin incorporation resulted not to affect oil oxidative kinetics, silybin 352 
concentration decreased during storage. Such a decrease was greater in extra virgin and 353 
sunflower oil than in castor oil. This instability rank is consistent with that relevant to the 354 
susceptibility to oxidation of the carrier oils considered. Although additional studies should be 355 
accomplished to fully elucidate the mechanism of silybin degradation in lipid carriers, the 356 
information acquired represents an important contribution for the design and fabrication of 357 
silymarin delivering nanoemulsions. 358 
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Figure captions 471 
Figure 1. Free fatty acids (FFA) release from sunflower oil, extra virgin olive oil and castor 472 
oil based nanoemulsions enriched with silymarin.  473 
Figure 2. Percentage of residual oxygen in sunflower oil, extra virgin olive oil and castor oil 474 
based nanoemulsions with and without silymarin, as a function of storage time at 20 °C. 475 
Figure 3. Changes in hydroperoxide concentration in sunflower oil, extra virgin olive oil and 476 
castor oil based nanoemulsions with and without silymarin, as a function of storage time at 20 477 
°C.  478 
Figure 4. Silybin concentration in sunflower oil, extra virgin olive oil and castor oil based 479 
nanoemulsions enriched with silymarin, as a function of storage time at 20 °C.  480 
Table captions 481 
Table 1. Silybin solubility in water, sunflower oil, extra virgin olive oil, castor oil and Tween 482 
80. 483 
Table 2. Mean particle diameter of sunflower oil, extra virgin olive oil and castor oil based 484 
nanoemulsions enriched with silymarin.  485 
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Table 3. Silybin concentration (%) in mixed micelle (i.e. in vitro bioaccessibility) and pellet 486 
after in vitro digestion of sunflower oil, extra virgin olive oil and castor oil based 487 
nanoemulsions enriched with silymarin. 488 
 489 
  
Figure 1. Free fatty acids (FFA) release from sunflower oil, extra virgin olive oil and castor oil 
based nanoemulsions enriched with silymarin. 
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 Figure 2. Percentage of residual oxygen in sunflower oil, extra virgin olive oil and castor oil based 
nanoemulsions with and without silymarin, as a function of storage time at 20 °C. 
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 Figure 3. Changes in hydroperoxide concentration in sunflower oil, extra virgin olive oil and castor 
oil based nanoemulsions with and without silymarin, as a function of storage time at 20 °C.  
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 Figure 4. Silybin concentration in sunflower oil, extra virgin olive oil and castor oil based 
nanoemulsions enriched with silymarin, as a function of storage time at 20 °C.  
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Table 1. Silybin solubility in water, sunflower oil, extra virgin olive oil, castor oil and Tween 80. 
Medium Silybin 
(mg/g) 
Water  nd 
Sunflower oil 0.028±0.006
b
 
Extra virgin olive oil 0.009±0.002
a
 
Castor oil 0.668±0.072
c
 
Tween 80 2.061±0.110
d
 
a-d
: means with different letters are significantly different (p < 0.05) 
nd: not detectable 
 
Table
Table 2. Mean particle diameter of sunflower oil, extra virgin olive oil and castor oil based 
nanoemulsions enriched with silymarin.  
Storage time (days) Mean particle diameter (nm) 
 Sunflower oil  Extra virgin olive oil Castor oil 
0 208±39
a
 241±46
a
 307±52
b
 
15 208±37
a
 229±39
 a
 309±53
b
 
36 208±38
a
 235±48
a
 329±6
b
 
50 232±49
a
 235±47
a
 323±62
b
 
a-b 
means with different letters in the same row are significantly different (p<0.05) 
 
 
Table
Table 3. Silybin concentration (%) in mixed micelle (i.e. in vitro bioaccessibility) and pellet after in 
vitro digestion of sunflower oil, extra virgin olive oil and castor oil based nanoemulsions enriched 
with silymarin. 
Carrier oil Silybin (%)   
 Micelle  Pellet 
Sunflower oil 25.3±2.1
b
 78.1±6.5
a
 
Extra virgin olive oil 29.1±0.7
a
 71.1±4.5
ab
 
Castor oil 29.6±1.6
a
 68.0±0.6
b
 
a-b
 means with different letters are significantly different (p < 0.05) 
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